Status:
TERMINATED
Study Of Indiplon/Placebo With Sertraline In Insomnia Co-Existing With Depression
Lead Sponsor:
Neurocrine Biosciences
Conditions:
Insomnia
Depression
Eligibility:
All Genders
18-65 years
Phase:
PHASE3
Brief Summary
The goal of this study is to determine whether indiplon, when administered with sertraline, improves insomnia symptoms and depressive symptoms in subjects with both insomnia and depression.
Detailed Description
This Pfizer run study stopped due to the co-development program for indiplon being terminated between Pfizer and Neurocrine. The study was terminated on 16 November 2006. There were no safety issues l...
Eligibility Criteria
Inclusion
- DSM-IV defined insomnia
- DSM-IV defined Major Depression
Exclusion
- Current suicidal ideation or behavior
- Primary sleep disorder other than insomnia
Key Trial Info
Start Date :
November 1 2005
Trial Type :
INTERVENTIONAL
End Date :
April 1 2006
Estimated Enrollment :
380 Patients enrolled
Trial Details
Trial ID
NCT00232167
Start Date
November 1 2005
End Date
April 1 2006
Last Update
October 2 2007
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.